(Q50554687)

15 March 2018

title

Retreatment with telaprevir combination therapy in hepatitis C patients with well-characterized prior treatment response. (English)

1 reference

15 March 2018

author

Thomas Berg

5

1 reference

15 March 2018

Jean-Michel Pawlotsky

8

1 reference

15 March 2018

Stefan Zeuzem

9

object named as

Stefan Zeuzem

1 reference

15 March 2018

3

John G McHutchison

1 reference

15 March 2018

Geoffrey Dusheiko

11

object named as

Geoffrey Dusheiko

1 reference

15 March 2018

Peter Ferenci

6

object named as

Peter Ferenci

1 reference

15 March 2018

author name string

Andrew J Muir

1

1 reference

15 March 2018

Fred F Poordad

2

1 reference

15 March 2018

Mitchell L Shiffman

4

1 reference

15 March 2018

E Jenny Heathcote

7

1 reference

15 March 2018

Henk W Reesink

10

1 reference

15 March 2018

Emily C Martin

12

1 reference

15 March 2018

Shelley George

13

1 reference

15 March 2018

Robert S Kauffman

14

1 reference

15 March 2018

Nathalie Adda

15

1 reference

15 March 2018

language of work or name

English

0 references

publication date

1 November 2011

1 reference

15 March 2018

published in

Hepatology

1 reference

15 March 2018

volume

54

1 reference

15 March 2018

issue

5

1 reference

15 March 2018

page(s)

1538-1546

1 reference

15 March 2018

Global surveillance and control of hepatitis C. Report of a WHO Consultation organized in collaboration with the Viral Hepatitis Prevention Board, Antwerp, Belgium

cites work

1 reference

Diagnosis, management, and treatment of hepatitis C: an update

21 January 2018

1 reference

Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose

21 January 2018

1 reference

Peginterferon alfa-2b or alfa-2a with ribavirin for treatment of hepatitis C infection

21 January 2018

1 reference

Peginterferon alfa-2b and ribavirin: effective in patients with hepatitis C who failed interferon alfa/ribavirin therapy

21 January 2018

1 reference

Telaprevir and peginterferon with or without ribavirin for chronic HCV infection

21 January 2018

1 reference

Telaprevir with peginterferon and ribavirin for chronic HCV genotype 1 infection

21 January 2018

1 reference

Telaprevir for previously treated chronic HCV infection

21 January 2018

1 reference

American Gastroenterological Association medical position statement on the management of hepatitis C

21 January 2018

1 reference

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1002/HEP.24549

1 reference

15 March 2018

PubMed ID

22045671

1 reference

15 March 2018